Adipotide CAS 859216-15-2

Adipotide CAS 859216-15-2

Dosing pattern:Daily injections in primate study; no established human regimen.
Common side effects:Renal effects in preclinical primates; human profile unknown.
Availability:Research only; not for consumer use.

 

What is Adipotide CAS 859216-15-2 ?

 

Adipotide (CAS 859216-15-2) is a synthetic peptidomimetic compound studied for its ability to target adipose tissue vasculature. It has been investigated in preclinical models for its role in fat tissue reduction, metabolic regulation, and obesity-related research.

Adipotide works by binding to specific receptors expressed in the blood vessels that supply white adipose tissue. This mechanism makes it a subject of interest in weight loss research, metabolic syndrome studies, and anti-obesity drug development.

This product is supplied as high-purity research-grade peptide, suitable for laboratory and preclinical applications.

 

Technical Specification

 

 

Item Specification
Product Name Adipotide
CAS Number 859216-15-2
Synonyms FTTP Peptide; Fat-Targeting Peptidomimetic
Molecular Type Peptidomimetic
Peptide Class Adipose vasculature-targeting peptide
Molecular Structure Synthetic cyclic peptidomimetic
Sequence Information Proprietary peptidomimetic sequence
Molecular Weight Approx. 4–5 kDa 
Purity ≥98% (HPLC)
Appearance White to off-white lyophilized powder
Solubility Soluble in sterile water, PBS, or physiological buffer
Reconstitution Recommended in sterile water or bacteriostatic water
Stability Stable under recommended storage conditions
Storage Conditions Store at -20°C; avoid repeated freeze–thaw cycles
Shelf Life Typically 24 months when properly stored
Endotoxin Level <0.1 EU/mg 
Analytical Methods HPLC purity testing
Packaging Sterile vials, sealed under controlled conditions
Intended Use Research and laboratory use only

 

 


 Key Benefits of Adipotide

 

  • Targeted approach to adipose tissue
  • Studied in obesity and metabolic research models
  • Supports fat metabolism and weight regulation research
  • Useful for preclinical anti-obesity drug development
  • High-purity peptide for reproducible laboratory results

 

Applications of Adipotide 

 

  • Obesity research
  • Fat loss and metabolic studies
  • Adipose tissue biology research
  • Preclinical anti-obesity drug screening
  • Endothelial apoptosis pathway studies

 

 Mechanism of Action 

Adipotide functions through a targeted vascular mechanism:

1. Selective Binding to Adipose Vasculature

Targets receptors expressed in the blood vessels of white adipose tissue.

2. Disruption of Blood Supply

Induces apoptosis in adipose tissue endothelial cells.

3. Reduction of Fat Tissue Mass

Decreased blood flow leads to reduction of white fat tissue in experimental models.

4. Metabolic Impact

Preclinical studies suggest effects on insulin sensitivity and metabolic markers.

Summary: Adipotide is studied as a fat-targeting peptide that reduces adipose tissue by disrupting its vascular supply in research models.

product-1200-1200

 

 

 


 Side Effects

 

Based on animal studies and experimental data:

  • Possible renal stress in high-dose models
  • Changes in kidney function markers observed in some studies
  • Injection site irritation in experimental settings
  • Not approved for human use

Note: Adipotide is strictly for research purposes only. Not intended for human or veterinary consumption.

 

Comparison: Adipotide  vs  Semaglutide  vs  AOD-9604

 
Feature Adipotide Semaglutide AOD-9604
Target Adipose vasculature GLP-1 receptor Lipolysis pathway
Mechanism Vascular apoptosis Appetite regulation Fat metabolism modulation
Research Stage Preclinical Approved drug Experimental
Focus Fat tissue reduction Appetite & glucose control Fat breakdown support

 

Summary:
Adipotide differs from GLP-1 agonists and metabolic peptides by directly targeting the blood supply of fat tissue, rather than regulating appetite or glucose metabolism.

 

FAQ 

 

Q1: What is Adipotide used for?
A1: It is used in preclinical research focused on obesity, fat reduction, and metabolic regulation.

Q2: How does Adipotide reduce fat in research models?
A2: It targets adipose tissue vasculature, leading to reduced blood supply and decreased fat mass.

Q3: Is Adipotide approved for human use?
A3: No. It is a research compound and not approved for clinical use.

Q4: What is the purity of the product?
A4: ≥98% purity, verified by HPLC.

Q5: How should Adipotide be stored?
A5: Store at -20°C, protected from moisture and light.

Q6: Are there known side effects?
A6: Preclinical studies report potential kidney-related effects at higher doses.

Why Choose NPX BIO Adipotide peptide?

 

  • Research-grade purity ≥98%
  • Verified analytical testing (HPLC)
  • Suitable for obesity and metabolic research
  • COA available
  • Reliable supply for laboratories and research institutions

certifications

certifactions

 

 

Shipping methods

 

Shipping Terms 1

 

Country Delivery time 
Untied states  7-15 DAYS
Australia 7-12 DAYS
Germany 7-12 DAYS
Canada 8-10 DAYS
New zealand 7-10 DAYS
Uk 5-10 DAYS
Thailand 5-8 DAYS
Malaysia 5-8 DAYS
Vietnam 5-8 DAYS

 

The delivery time shown above is an estimate. Shipping routes and freight capacity may change from time to time. For the most accurate delivery schedule, please contact us directly.

 

Payment terms

 

088

 

Hot Tags: adipotide cas 859216-15-2, China adipotide cas 859216-15-2 manufacturers, suppliers, factory, Cagrilintide Powder fat loss, CAS 3051672 09 1, weight loss collagen peptides, semaglutide peptide oral, orlistat peptide pills, semaglutide and aod 9604

Send Inquiry

(0/10)

clearall